Skip to content

Losartan D3

Losartan D3

Product Description
CAT No.
ALN-L028D02
CAS No.
1030936-74-3
Mol. F.
C22H20D3ClN6O
Mol. Wt.
425.9
Stock
Please Inquire
Chemical Name : (1-((2′-(1H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-2-(butyl-4,4,4-d3)-4-chloro-1H-imidazol-5-yl)methanol
Smiles : OCC1=C(Cl)N=C(CCCC([2H])([2H])[2H])N1CC2=CC=C(C3=C(C4=NN=NN4)C=CC=C3)C=C2
Inchi : InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28)/i14D2

Development and validation of a stability-indicating HPLC method for the simultaneous determination of Losartan potassium, hydrochlorothiazide, and their degradation products

Deanne L. Hertzog a,*, Jennifer Finnegan McCafferty b , Xueguang Fang b , R. Jeffrey Tyrrell c , Robert A. ReednJournal of Pharmaceutical and Biomedical Analysis 30 (2002) 747u2013760

An Efficient, Commercially Viable, and Safe Process for Preparation of Losartan Potassium, an Angiotensin II Receptor Antagonist

, Jennifer Finnegan McCafferty b , Xueguang Fang b , R. Jeffrey Tyrrell c , Robert A. Reed – Journal of Pharmaceutical and Biomedical Analysis 30 (2002) 747–760
Suri Babu Madasu,†,‡ N. A. Vekariya,

Request For Quotation